NCT05773651Recruiting
Rare Tumours in Children and Adolescents (STEP)
Rare Tumours in Children and Adolescents (STEP 2.0) - Register for the Documentation of Rare Tumours in Children and Adolescents
Source: ClinicalTrials.gov · Last updated 1 Oct 2024 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
The aim of the STEP registry is to collect and evaluate experience and data on the diagnosis and treatment of rare childhood tumors in order to use the knowledge gained to improve the treatment prospects for our patients. The rarity of a disease should not be a disadvantage for the young patients.
- Status (registry)
- Recruiting
- Study type
- Observational
- Enrollment
- 10000 (estimated)
- First submitted
- 6 Mar 2023
- Start date
- 11 Jan 2023
- Primary completion date
- Jan 2050
- Lead sponsor
- University Hospital Tuebingen
- Diseases
- Childhood cancers
- NCT number
- NCT05773651
What you commit to
- Study type: Observational
- Planned participants: 10000
- From 11 Jan 2023 to the primary completion date, Jan 2050
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Registration of the tumor diagnosis in a prospective therapy study/ another clinical registry of the GPOH
Other
- Lack of information, explanation and/or written consent of the patient or the legal guardian.
Who the study is looking for
- Diagnosis of a rare solid tumor
- Age at diagnosis: Neonatal period to 18 years (In the case of young adults, registration in the database and/or referral to advisory contact persons within the framework of the competence network can take place upon request and after declaration of consent.)
- Information, education, written consent of the patient or the guardian
- Not recorded in any of the existing clinical studies/ registers of the German Society for Pediatric Oncology and Hematology (GPOH)
Age in the registry: 1 day to 18 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| University Hospital Tübingen Coordinator of this site? Confirm its status | Tübingen | Germany | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.